Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice

Experimental Neurology

Volumn 149, Issue 2, 1998, Pages 447-454

  McBride, P A ^a   Wilson, M I ^a   Eikelenboom, P ^b   Tunstall, A ^c   Bruce, M E ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

Amyloid plaques; HSPG immunocytochemistry; PrP; Scrapie

Indexed keywords

PROTEOHEPARAN SULFATE;

ALLELE; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; DISEASE TRANSMISSION; IMMUNOCYTOCHEMISTRY; MOUSE; NEUROANATOMY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCRAPIE;

EID: 0032006297     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6740     Document Type: Article

References (39)

1. Abraham C. R., Selkoe D. J., Potter H. Immunochemical identification of the serine protease inhibitor α-1 antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
2. Bruce M. E., Fraser H. Amyloid plaques in the brains of mice infected with scrapie: Morphological variation and staining properties. Neuropathol. Appl. Neurobiol. 1:1975;189-202.
3. Bruce M. E., Dickinson A. G., Fraser H. Cerebral amyloidosis in scrapie in the mouse: Effect of agent strain and mouse genotype. Neuropathol. Appl. Neurobiol. 2:1976;417-478.
4. Bruce M. E. Serial studies on the development of cerebral amyloidosis and vacuolar degeneration in murine scrapie. J. Comp. Pathol. 91:1981;589-597.
5. Bruce M. E., McBride P. A., Farquhar C. F. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci. Lett. 102:1989;1-6.
6. Bruce M. E., McBride P. A., Jeffrey M., Rozemuller J. M., Eikelenboom P. PrP in Scrapie and β/A4 in Alzheimer's disease show similar patterns of deposition in the brain. Alzheimer's Disease: Advances in Clinical and Basic Research. 1993;Wiley, Chichester. p. 481-487.
7. Bruce M. E., McBride P. A., Jeffrey M., Scott J. R. PrP in pathology and pathogenesis in scrapie-infected mice. Mol. Neurobiol. 8:1994;105-112.
8. Caughey B. W., Dong S., Bhat K. S., Ernst D., Hayes S. F., Caughey W. S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry. 30:1991;7672-7680.
9. Caughey B., Raymond G. J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67:1993;643-650.
10. Caughey B. Scrapie associated PrP accumulation and its prevention: Insights from cell culture. Br. Med. Bull. 49:1993;860-872.
11. Farquhar C. F., Somerville R. A., Dornan J., Armstrong D., Birkett C., Hope J. A review of the detection of PrPsc. Bradley R., Marchart B. Proceedings of a Consultation on BSE with the Scientific Veterinary Committee of the Commission of the European Communities, 14-15 September, 1993, Brussels, BSE Update. 1994;301-313.
12. Fraser H., McBride P. A. Parallels and contrasts between scrapie and dementia of the Alzheimer Type and ageing: Strategies and problems for experiments involving life span studies. Traber J., Gispen W. H. Senile Dementia of the Alzheimer Type. 1985;250-268 Springer-Verlag, Berlin.
13. Fraser P. E., Nguyen J. T., Chin D. T., Kirschner D. A. Effects of sulfate ions on Alzheimer β/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59:1992;1531-1540.
14. Gasset M., Baldwin M. A., Fletterick R. J., Prusiner S. B. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. Natl. Acad. Sci. USA. 90:1993;1-5.
15. Gerstmann J., Sträussler E., Scheinker I. Über eine eigenartige hereditär-familiäre Erkrankung des Zentral-nervensystems zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z. Neurol. 154:1936;736-762.
16. Guiroy D. C., Yanigihara R., Gajdusek D. C. Localisation of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses. Acta Neuropathol. 82:1991;87-92.
17. Jeffrey M., Goodsir C. M., Bruce M. E., McBride P. A., Scott J. R., Halliday W. G. Brain Res. 656:1994;329-343.
18. Jeffrey M., Goodsir C. M., Bruce M. E., McBride P. A., Farquhar C. Morphogenesis of amyloid plaques in 87V murine scrapie. Neuropathol. Appl. Neurobiol. 20:1994;535-542.
19. Jeffrey M., Goodsir C. M., Bruce M. E., McBride P. A., Fraser J. R. In vivo. Neuropathol. Appl. Neurobiol. 23:1997;93-101.
20. Kisilevsky R. An interaction between basement-membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's Disease. Lab. Invest. 72:1995;272-282.
21. Kisilevsky R., Lemieux L. J., Fraser P. E., Kong X. Q., Hultin P. G., A W., Szarek. Arresting amyloidosis in-vivo using small molecule anionic sulphonates or sulfates: Implications for Alzheimer's disease. Nat. Med. 1:1995;143-148.
22. Kisilevsky R., Fraser P. Proteoglycans and amyloid fibrillogenesis, CIBA Foundation Symposia 199. Bock G. R., Goode J. A. The Nature and Origin of Amyloid Fibrils. 1996;58-72 Wiley, Toronto.
23. Klatzo I., Gajdusek D. C., Zigas V. Pathology of kuru. Lab. Invest. 8:1959;799-847.
24. Mann D. M. A., Iwatsubo T., Snowden J. S. Atypical amyloid (Aβ) deposition in the cerebellum in Alzheimer's disease: An immunohistochemical study using end-specific Aβ monoclonal antibodies. Acta. Neuropathol. 91:1996;647-653.
25. Mathews M. B., Decker L. The effect of acid mucopolysaccharides and acid mucopolysaccharide-proteins on fibril formation from collagen solution. Biochem. J. 9:1968;517-524.
26. Puchtler H., Sweat F., Levine M. On the binding of Congo red by amyloid. J. Histochem. Cytochem. 10:1962;355-364.
27. Rozemuller J. M., Eikelenboom P., Stam F. C., Beyreuther K., Masters C. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition. J. Neuropathol. Exp. Neurol. 48:1989;674-691.
28. Rozemuller J. M., Stam F. C., Eikelenboom P. Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci. Lett. 119:1990;75-78.
29. Snow A. D., Wight T. N. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol. Aging. 10:1989;481-497.
30. Snow A. D., Wight T. N., Nochlin D., Koike Y., Kimata K., DeArmond S. J., Prusiner S. B. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gertmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab. Invest. 63:1990;601-611.
31. Snow A. D., Mar H., Nochlin D., Sekiguchi R. T., Kimata K., Koike Y., Wight T. N. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137:1990;1253-1270.
32. Snow A. D., Henderson M., Nochlin D., Kresse H., Wight T. N. Peripheral distribution of dermatan sulfate proteoglycans (Decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J. Histochem. Cytochem. 40:1992;105-113.
33. Snow A. D., Sekiguchi R. T., Nochlin D., Lalarea R. N., Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am. J. Pathol. 144:1994;337-347.
34. Snow A. D., Sekiguchi R. T., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W. A., Morgan D. G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A-Alpha amyloid in rat brain. Neuron. 12:1994;219-234.
35. Van den Born J., Van den Heuvel L. P. W. G., Bakker M. A. H., Veerkamp J. H., Assmann K. J. M., Berden J. H. M. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: Characterization and immunohistological application in human tissues. J. Histochem. Cytochem. 42:1994;89-102.
36. Wight T. N., Kinsella M. G., Qwarnstrom E. E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell. Biol. 4:1992;793-801.
37. Will R. G., Ironside J. W., Zeidler M., Cousens S. N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P. G. A new variant of Creutzfeldt-Jakob disease in the U. K. Lancet. 347:1996;921-925.
38. Wood G. C. The formation of fibrils from collagen solutions. Biochem. J. 75:1960;605-612.
39. Zhan S-S., Veerhuis R., Kamphorst W., Eikelenboom P. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration. 4:1995;291-297.